These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8749023

  • 1. Psychostimulant-like effects of p-fluoroamphetamine in the rat.
    Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE.
    Eur J Pharmacol; 1995 Dec 12; 287(2):105-13. PubMed ID: 8749023
    [Abstract] [Full Text] [Related]

  • 2. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D, Nichols DE.
    Eur J Pharmacol; 1994 Jun 02; 258(1-2):1-13. PubMed ID: 7925587
    [Abstract] [Full Text] [Related]

  • 3. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD, Nichols DE, Yim GK.
    Biochem Pharmacol; 1987 Jul 15; 36(14):2297-303. PubMed ID: 2886126
    [Abstract] [Full Text] [Related]

  • 4. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE.
    Pharmacol Biochem Behav; 1996 Jan 15; 53(1):99-105. PubMed ID: 8848466
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    Li Q, Murakami I, Stall S, Levy AD, Brownfield MS, Nichols DE, Van de Kar LD.
    J Pharmacol Exp Ther; 1996 Dec 15; 279(3):1261-7. PubMed ID: 8968349
    [Abstract] [Full Text] [Related]

  • 6. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP, Conarty PF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):9-16. PubMed ID: 1685125
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B, Imam SZ, Blough B, Slikker W, Ali SF.
    Ann N Y Acad Sci; 2002 Jun 23; 965():410-20. PubMed ID: 12105116
    [Abstract] [Full Text] [Related]

  • 8. 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
    Huang X, Nichols DE.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):291-6. PubMed ID: 8104811
    [Abstract] [Full Text] [Related]

  • 9. p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
    Huang X, Marona-Lewicka D, Nichols DE.
    Eur J Pharmacol; 1992 Dec 08; 229(1):31-8. PubMed ID: 1473561
    [Abstract] [Full Text] [Related]

  • 10. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine.
    Johnson MP, Huang XM, Oberlender R, Nash JF, Nichols DE.
    Eur J Pharmacol; 1990 Nov 20; 191(1):1-10. PubMed ID: 1982656
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D, Mennini T, Gobbi M.
    Br J Pharmacol; 1997 Aug 20; 121(8):1735-43. PubMed ID: 9283711
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R, Nichols DE.
    Psychopharmacology (Berl); 1988 Aug 20; 95(1):71-6. PubMed ID: 2898791
    [Abstract] [Full Text] [Related]

  • 17. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues.
    Nash JF, Nichols DE.
    Eur J Pharmacol; 1991 Jul 23; 200(1):53-8. PubMed ID: 1722755
    [Abstract] [Full Text] [Related]

  • 18. Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats.
    Glick SD, Carlson JN, Baird JL, Maisonneuve IM, Bullock AE.
    Brain Res; 1988 Nov 08; 473(1):161-4. PubMed ID: 3208119
    [Abstract] [Full Text] [Related]

  • 19. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R, Nichols DE.
    J Pharmacol Exp Ther; 1990 Dec 08; 255(3):1098-106. PubMed ID: 1979813
    [Abstract] [Full Text] [Related]

  • 20. Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
    Gagnaire F, Micillino JC.
    Toxicology; 2006 Jan 16; 217(2-3):91-104. PubMed ID: 16246478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.